| Product Code: ETC7744309 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Opioid Receptor Agonist Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Opioid Receptor Agonist Market - Industry Life Cycle |
3.4 Japan Opioid Receptor Agonist Market - Porter's Five Forces |
3.5 Japan Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Japan Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F |
3.7 Japan Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Japan Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Japan Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Japan Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Opioid Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Japan |
4.2.2 Growing awareness and acceptance of opioid therapy for pain management |
4.2.3 Rising geriatric population in Japan requiring pain management solutions |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment and strict controls on opioid prescriptions in Japan |
4.3.2 Social stigma associated with opioid use leading to hesitancy among patients and healthcare providers |
5 Japan Opioid Receptor Agonist Market Trends |
6 Japan Opioid Receptor Agonist Market, By Types |
6.1 Japan Opioid Receptor Agonist Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Japan Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Japan Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.4 Japan Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 Japan Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.6 Japan Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.7 Japan Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Opioid Receptor Agonist Market, By Receptor Binding |
6.2.1 Overview and Analysis |
6.2.2 Japan Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F |
6.2.3 Japan Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F |
6.3 Japan Opioid Receptor Agonist Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Japan Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F |
6.3.3 Japan Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.3.4 Japan Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F |
6.3.5 Japan Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Opioid Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Japan Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 Japan Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 Japan Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Japan Opioid Receptor Agonist Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Japan Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Japan Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Japan Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Japan Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Japan Opioid Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Japan Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Japan Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Japan Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Japan Opioid Receptor Agonist Market Import-Export Trade Statistics |
7.1 Japan Opioid Receptor Agonist Market Export to Major Countries |
7.2 Japan Opioid Receptor Agonist Market Imports from Major Countries |
8 Japan Opioid Receptor Agonist Market Key Performance Indicators |
8.1 Number of new opioid receptor agonist drug approvals in Japan |
8.2 Prescription rates of opioid receptor agonists in Japan |
8.3 Patient satisfaction and pain relief outcomes with opioid therapy in Japan |
9 Japan Opioid Receptor Agonist Market - Opportunity Assessment |
9.1 Japan Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Japan Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F |
9.3 Japan Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Japan Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Japan Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Japan Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Opioid Receptor Agonist Market - Competitive Landscape |
10.1 Japan Opioid Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 Japan Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here